Copyright
©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Cardiol. Aug 26, 2010; 2(8): 243-250
Published online Aug 26, 2010. doi: 10.4330/wjc.v2.i8.243
Published online Aug 26, 2010. doi: 10.4330/wjc.v2.i8.243
Atrial fibrillation and inflammation
Mehmet Ozaydin, Department of Cardiology, School of Medicine, Suleyman Demirel University, 32040, Isparta, Turkey
Author contributions: Ozaydin M solely contributed to this paper.
Correspondence to: Mehmet Ozaydin, MD, Associate professor, Department of Cardiology, School of Medicine, Suleyman Demirel University, Kurtulus Mah, 122. Cad. Hatice Halici Apt. No: 126/15, 32040, Isparta, Turkey. mehmetozaydin@hotmail.com
Telephone: +90-532-4139528 Fax: +90-246-2180163
Received: March 3, 2010
Revised: May 6, 2010
Accepted: May 13, 2010
Published online: August 26, 2010
Revised: May 6, 2010
Accepted: May 13, 2010
Published online: August 26, 2010
Abstract
Atrial fibrillation (AF) is the most common clinical arrhythmia. Recent investigations have suggested that inflammation might have a role in the pathophysiology of AF. In this review, the association between inflammation and AF, and the effects of several agents that have anti-inflammatory actions, such as statins, polyunsaturated fatty acids, corticosteroids and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, have been investigated.
Keywords: Atrial fibrillation; Inflammation; Statins